Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage.
Frémond ML, Legendre M, Fayon M, Clement A, Filhol-Blin E, Richard N, Berdah L, Roullaud S, Rice GI, Bondet V, Duffy D, Sileo C, Ducou le Pointe H, Begueret H, Coulomb A, Neven B, Amselem S, Crow Y, Nathan N.
Frémond ML, et al. Among authors: coulomb a.
Thorax. 2020 Jan;75(1):92-95. doi: 10.1136/thoraxjnl-2019-213892. Epub 2019 Oct 30.
Thorax. 2020.
PMID: 31666386